TNF inhibitor exposure and cancer? Data of case/non case study in French PharmacoVigilance Database

Type de document :
Communication dans un congrès
17th Annual Meeting of French Society of Pharmacology and Therapeutics, the 80th Annual Meeting of Society of Physiology, the 34th Pharmacovigilance Meeting, the 14th APNET Seminar and the 11th CHU CIC Meeting, Apr 2013, Angers, France. Fundamental & Clinical Pharmacology, 27 (Supplément 1), pp.35, 2013, Abstracts of the 17th Annual Meeting of French Society of Pharmacology and Therapeutics, the 80th Annual Meeting of Society of Physiology, the 34th Pharmacovigilance Meeting, the 14th APNET Seminar and the 11th CHU CIC Meeting, 22–24 April 2013, Angers, France
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01532048
Contributeur : Imopa Ul <>
Soumis le : vendredi 2 juin 2017 - 12:54:48
Dernière modification le : vendredi 9 février 2018 - 14:28:10

Identifiants

  • HAL Id : hal-01532048, version 1

Citation

L. Saliba, M. Aboutaam, V. Rousseau, L. Chebane, N. Petitpain, et al.. TNF inhibitor exposure and cancer? Data of case/non case study in French PharmacoVigilance Database. 17th Annual Meeting of French Society of Pharmacology and Therapeutics, the 80th Annual Meeting of Society of Physiology, the 34th Pharmacovigilance Meeting, the 14th APNET Seminar and the 11th CHU CIC Meeting, Apr 2013, Angers, France. Fundamental & Clinical Pharmacology, 27 (Supplément 1), pp.35, 2013, Abstracts of the 17th Annual Meeting of French Society of Pharmacology and Therapeutics, the 80th Annual Meeting of Society of Physiology, the 34th Pharmacovigilance Meeting, the 14th APNET Seminar and the 11th CHU CIC Meeting, 22–24 April 2013, Angers, France. 〈hal-01532048〉

Partager

Métriques

Consultations de la notice

39